Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$0.15 - $0.37 $1,305 - $3,219
-8,700 Reduced 46.52%
10,000 $1.58 Million
Q1 2024

May 14, 2024

BUY
$0.19 - $0.3 $3,553 - $5,610
18,700 New
18,700 $5.07 Million

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $124M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Trajan Wealth LLC Portfolio

Follow Trajan Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trajan Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trajan Wealth LLC with notifications on news.